A Double-Blind Randomized Controlled Trial of Ethyl-Eicosapentaenoate (EPA-E) for Major Depressive Disorder

OBJECTIVE: We examined the efficacy and tolerability of ethyl-eicosapentaenoate (EPA-E) monotherapy for major depressive disorder (MDD) in a double-blind, randomized controlled pilot study. METHODS: 57 adults with DSM-IV MDD were randomized from 1/2003-6/2006 to receive 1 gram/day of EPA or placebo...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mischoulon, David, Papakostas, George I., Dording, Christina M., Farabaugh, Amy H., Sonawalla, Shamsah B., Agoston, Monica, Smith, Juliana, Beaumont, Erin, Dahan, Liat, Alpert, Jonathan E., Nierenberg, Andrew A., Fava, Maurizio
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2918427/
https://ncbi.nlm.nih.gov/pubmed/19709502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.08m04603
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires